Search results
Results from the WOW.Com Content Network
The source for the data below is the OECD Health Statistics 2018, released by the OECD in June 2018 and updated on 8 November 2018. [1]The unit of measurement used by the OECD is defined daily dose (DDD), defined as "the assumed average maintenance dose per day for a drug used on its main indication in adults". [2]
This is a list of countries by quality of healthcare as published by the Organisation for Economic Co-operation and Development . [ 1 ] The list includes 7 types of cancer along with strokes and heart attacks.
The list is frequently used by countries to help develop their own local lists of essential medicines. [2] As of 2016, more than 155 countries have created national lists of essential medicines based on the World Health Organization's model list. [1] This includes both developed and developing countries. [2] [3]
Mental, neurological, and substance use disorders make a substantial contribution to the global burden of disease (GBD). [12] This is a global measure of so-called disability-adjusted life years (DALY's) assigned to a certain disease/disorder, which is a sum of the years lived with disability and years of life lost due to this disease within the total population.
For most countries among the 10 studied, the number of people who experience depression during their lifetimes falls within an 8–12% range. [ 3 ] [ 4 ] In North America, the probability of having a major depressive episode within any year-long period is 3–5% for males and 8–10% for females.
Researchers tested the antidepressant in nearly 1,500 Brazilians recently infected with coronavirus who were at risk of severe illness because of other health problems, such as diabetes.
Most antidepressants aim for the same target: the monoamine system. They work by raising levels of one or more of the monoamine neurotransmitters in the brain that are involved in mood—serotonin ...
Most antidepressants will hinder the breakdown of serotonin, norepinephrine, and/or dopamine. A commonly used class of antidepressants are called selective serotonin reuptake inhibitors (SSRIs), which act on serotonin transporters in the brain to increase levels of serotonin in the synaptic cleft. [22]